Kadir is a chemical engineer by training. He manages research grants in the areas of chemistry, biotechnology, and chemical biology. He also oversees small business grants and postdoctoral fellowships within the Division of Pharmacology, Physiology, and Biological Chemistry.
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 Clinical Trial Not Allowed) PAR-25-202
This NOFO solicits R21 applications with innovative, high-risk concepts for developing new technologies or radically improving existing ones. It supports novel concepts that haven’t been tested for feasibility. Because inclusion of unpublished or preliminary data isn’t allowed under this NOFO, NIGMS expects the proposed projects to be high risk.
National Institute of
